IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and Oc… Read more
IRIDEX Corporation (IRIX) - Total Liabilities
Latest total liabilities as of September 2025: $23.67 Million USD
Based on the latest financial reports, IRIDEX Corporation (IRIX) has total liabilities worth $23.67 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
IRIDEX Corporation - Total Liabilities Trend (1995–2024)
This chart illustrates how IRIDEX Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
IRIDEX Corporation Competitors by Total Liabilities
The table below lists competitors of IRIDEX Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Skolon AB
ST:SKOLON
|
Sweden | Skr91.34 Million |
|
Shanghai Lingyun Industries Development Co Ltd
SHG:900957
|
China | $423.71 Million |
|
ATrack Technology
TWO:6465
|
Taiwan | NT$75.05 Million |
|
China Medical & HealthCare Group Limited
PINK:COLRF
|
USA | $1.54 Billion |
|
ProStar Holdings Inc
OTCQX:MAPPF
|
USA | $844.82K |
|
Adisyn Ltd
AU:AI1
|
Australia | AU$1.32 Million |
Liability Composition Analysis (1995–2024)
This chart breaks down IRIDEX Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.83 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IRIDEX Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IRIDEX Corporation (1995–2024)
The table below shows the annual total liabilities of IRIDEX Corporation from 1995 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $27.04 Million | +8.53% |
| 2023-12-31 | $24.91 Million | -0.58% |
| 2022-12-31 | $25.06 Million | -1.30% |
| 2021-12-31 | $25.39 Million | +139.44% |
| 2020-12-31 | $10.60 Million | -12.43% |
| 2019-12-31 | $12.11 Million | +3.39% |
| 2018-12-31 | $11.71 Million | +5.28% |
| 2017-12-31 | $11.12 Million | +23.82% |
| 2016-12-31 | $8.98 Million | +10.44% |
| 2015-12-31 | $8.13 Million | +0.66% |
| 2014-12-31 | $8.08 Million | +3.31% |
| 2013-12-31 | $7.82 Million | +11.65% |
| 2012-12-31 | $7.01 Million | -27.93% |
| 2011-12-31 | $9.72 Million | -0.71% |
| 2010-12-31 | $9.79 Million | -26.17% |
| 2009-12-31 | $13.27 Million | -19.50% |
| 2008-12-31 | $16.48 Million | -40.82% |
| 2007-12-31 | $27.84 Million | +247.18% |
| 2006-12-31 | $8.02 Million | +21.75% |
| 2005-12-31 | $6.59 Million | -9.89% |
| 2004-12-31 | $7.31 Million | +46.05% |
| 2003-12-31 | $5.00 Million | +22.85% |
| 2002-12-31 | $4.07 Million | +3.01% |
| 2001-12-31 | $3.96 Million | -12.60% |
| 2000-12-31 | $4.53 Million | -12.32% |
| 1999-12-31 | $5.16 Million | +106.44% |
| 1998-12-31 | $2.50 Million | -10.71% |
| 1997-12-31 | $2.80 Million | +27.27% |
| 1996-12-31 | $2.20 Million | +29.41% |
| 1995-12-31 | $1.70 Million | -- |